Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clene, Inc.

http://clene.com

Latest From Clene, Inc.

Finance Watch: Public Companies Pursue All Options To Fund R&D, Launches

Public Company Edition: Follow-on offerings may not be the favored path to funding development programs or product launches after major milestones in the current environment. Amicus secured $430m in a deal with Blackstone, while OPKO’s Modex garnered up to $168m from BARDA.

Finance Watch Financing

Apellis Follows Wave Life By Shelving ALS Candidate After Trial Miss

Apellis’s pegcetacoplan – approved for two other indications – will not go forward in amyotrophic lateral sclerosis after a Phase II failure, two days after Wave Life made a similar call in the neurodegenerative disease.

Clinical Trials Drug Approval Standards

Clene Confident In Phase III Plans For CNM-Au8 In ALS With Six-Month Data

The company announced detailed data for the drug in the HEALEY-ALS Platform Trial, where the cohort of the Phase II/III study testing it nevertheless failed to meet the primary endpoint.

Business Strategies Clinical Trials

Prilenia Plans To Continue With Pridopidine In ALS Despite Platform Study Miss

Pridopidine is the latest ALS drug candidate to miss the primary endpoint in the HEALEY-ALS platform study, but the S1R agonist did indicate potential benefits in speech and a key biomarker of the disease.

Clinical Trials Drug Approval Standards
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
  • Biotechnology
    • Nanotechnology, Chips, etc.
  • Other Names / Subsidiaries
    • Clene
    • Clene Nanomedicine, Inc.
UsernamePublicRestriction

Register